These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2545075)
1. Response to growth hormone-releasing hormone as evidence of hypothalamic defect in optic nerve hypoplasia. Leaf AA; Ross RJ; Jones RB; Besser GM; Savage MO Acta Paediatr Scand; 1989 May; 78(3):436-9. PubMed ID: 2545075 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic use of the GRF test in the study of GH secretion]. Ramos M; Fernández A; Ferrández A; Mayayo E; Guallar A An Esp Pediatr; 1987 Oct; 27(4):269-73. PubMed ID: 2892455 [TBL] [Abstract][Full Text] [Related]
3. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Looij BJ; Nieuwenhuijzen Kruseman AC; Mudde AH; Frölich M; Piaditis GP; Hodgkinson SC; McLean C; Grossman A; Coy DH; Rees LH Clin Endocrinol (Oxf); 1986 Feb; 24(2):149-56. PubMed ID: 2871949 [TBL] [Abstract][Full Text] [Related]
4. Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release. Blacklay A; Grossman A; Ross RJ; Savage MO; Davies PS; Plowman PN; Coy DH; Besser GM J Endocrinol; 1986 Jan; 108(1):25-9. PubMed ID: 2868066 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency? Smith PJ; Brook CG Arch Dis Child; 1988 Jun; 63(6):629-34. PubMed ID: 2898924 [TBL] [Abstract][Full Text] [Related]
6. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults. Grossman A; Savage MO; Lytras N; Preece MA; Sueiras-Diaz J; Coy DH; Rees LH; Besser GM Clin Endocrinol (Oxf); 1984 Sep; 21(3):321-30. PubMed ID: 6236914 [TBL] [Abstract][Full Text] [Related]
7. The influence of dexamethasone on growth hormone (GH). Response to GH-releasing hormone in normal men. Rupprecht R; Niehaus A; Lesch KP J Neural Transm Gen Sect; 1990; 79(1-2):51-7. PubMed ID: 2105096 [TBL] [Abstract][Full Text] [Related]
8. Use of continuous subcutaneous growth hormone-releasing hormone (GHRH (1-29)NH2) infusions to augment growth hormone secretion and to promote growth. Brain C; Hindmarsh PC; Pringle PJ; Brook CG Acta Paediatr Scand Suppl; 1989; 349():109-13; discussion 123-4. PubMed ID: 2546369 [TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-pituitary function in children with optic nerve hypoplasia. Costin G; Murphree AL Am J Dis Child; 1985 Mar; 139(3):249-54. PubMed ID: 2983530 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men. Barron JL; Coy DH; Millar RP Peptides; 1985; 6(3):575-7. PubMed ID: 2866496 [TBL] [Abstract][Full Text] [Related]
11. Congenital optic nerve hypoplasia with hypothalamic-pituitary dysplasia. A review of 16 cases. Margalith D; Tze WJ; Jan JE Am J Dis Child; 1985 Apr; 139(4):361-6. PubMed ID: 3976626 [TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) release after administration of GH-releasing hormone in relation to endogenous 24-h GH secretion in short children. Gelander L; Albertsson-Wikland K J Endocrinol; 1989 Jul; 122(1):61-8. PubMed ID: 2549156 [TBL] [Abstract][Full Text] [Related]
13. Effects of intranasal calcitonin administration on pituitary GH response to hGHRH (1-29)NH2 in normal adult subjects. Giustina A; Romanelli G; Doga M; Pizzocolo G; Giustina G Clin Endocrinol (Oxf); 1989 Jun; 30(6):699-704. PubMed ID: 2556224 [TBL] [Abstract][Full Text] [Related]
14. Comparison of growth hormone releasing hormone therapy and growth hormone therapy in growth hormone deficiency. Butenandt O; Staudt B Eur J Pediatr; 1989 Feb; 148(5):393-5. PubMed ID: 2537727 [TBL] [Abstract][Full Text] [Related]
15. The endocrine spectrum of septo-optic dysplasia. Izenberg N; Rosenblum M; Parks JS Clin Pediatr (Phila); 1984 Nov; 23(11):632-6. PubMed ID: 6488662 [TBL] [Abstract][Full Text] [Related]
16. Effect of repeated subcutaneous administration of growth hormone releasing factor (GRF 1-44) on hypophysis in GH-deficient children. Szarras-Czapnik M; Rymkiewicz-Kluczyńska B; Romer T Endokrynol Pol; 1987; 38(1):15-9. PubMed ID: 3123207 [No Abstract] [Full Text] [Related]
17. Responsiveness of pituitary hGH to GRH1-44 in juveniles with obesity. Pertzelan A; Keret R; Bauman B; Josefsberg Z; Ben-Zeev Z; Szoke B; Comaru-Schally AM; Schally AV; Laron Z Acta Endocrinol (Copenh); 1986 Feb; 111(2):151-3. PubMed ID: 3082093 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy. Grossman A; Lytras N; Savage MO; Wass JA; Coy DH; Rees LH; Jones AE; Besser GM Br Med J (Clin Res Ed); 1984 Jun; 288(6433):1785-7. PubMed ID: 6234047 [TBL] [Abstract][Full Text] [Related]
19. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome]. Schmitt K; Schober E; Birnbacher R; Frisch H Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324 [TBL] [Abstract][Full Text] [Related]
20. The effect of calcitonin on growth hormone secretion in man. Looij BJ; Roelfsema F; van der Heide D; Frölich M; Souverijn JH; Nieuwenhuijzen Kruseman AC Clin Endocrinol (Oxf); 1988 Nov; 29(5):517-27. PubMed ID: 2908103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]